Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-08

Clinical Trial Update: Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficiency of levamisole for maintaining remission after the first flare of steroid-sensitive nephrotic syndrome in children has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levamisole (levamisole)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: First Manifestation of Steroid Sensitive Nephrotic Syndrome | Phase 3 | Status: COMPLETED